This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer
A 2013 meta-analysis of randomized controlled trials (5 trials, 177 participants) found saffron was associated with a...
A 2013 meta-analysis of randomized controlled trials (5 trials, 177 participants) found saffron was associated with a large reduction in depressive symptoms versus placebo, and was comparable to standard antidepressants. Trials were small and mostly conducted in Iran, so saffron is best seen as a supportive option to discuss with a clinician — not a replacement for depression treatment.
| Study | Participants | Finding | Quality |
|---|---|---|---|
Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials Hausenblas HA, Saha D, Dubyak PJ, Anton SD — Journal of Integrative Medicine (2013) | 177 | Saffron was associated with a large reduction in depressive symptoms vs placebo (ES 1.62) and was comparable to antidepressants across 5 RCTs. | Moderate |
Saffron extract has been studied for supporting mood and was associated with reduced depressive symptoms in small randomized trials, with effects broadly comparable to standard antidepressants over 6–8 weeks (commonly ~30 mg/day). The evidence base is limited — small studies, mostly from one region — so results should be interpreted cautiously. This is supportive information, not a treatment plan: saffron is not a substitute for evidence-based depression care. If you are experiencing depression, and especially if you have any thoughts of self-harm, please reach out to a healthcare professional, and review supplements with your clinician (saffron may interact with antidepressants and blood thinners).
A meta-analysis of randomized trials found saffron was associated with reduced depressive symptoms versus placebo, with effects comparable to standard antidepressants in small, mostly Iran-based studies.
A meta-analysis of randomized trials found saffron was associated with a large reduction in depressive symptoms versus placebo, and was comparable to standard antidepressants. However, the trials were small and mostly from one region, so it is best viewed as a supportive option rather than a proven standalone treatment.
Trials commonly used around 30 mg/day of saffron extract over 6–8 weeks. Because saffron can be costly and quality varies, and because it may interact with antidepressants, discuss an appropriate product and dose with your clinician.
No. Although some trials compared it to antidepressants, the studies were small and short. Do not stop or change a prescribed antidepressant on your own — make any changes with your clinician.
If low mood is persistent, worsening, or affecting your daily life — or if you have any thoughts of harming yourself — please contact a healthcare professional or a crisis line right away. Supplements are not a substitute for proper care.
Bottom line: Saffron extract has clinical-trial evidence for mild-to-moderate depressive symptoms at 28-30mg daily. Do not combine with SSRIs/SNRIs/MAOIs (serotonin syndrome risk) without prescriber sign-off.
Product ComparisonSee our ranked picks
Condition Guide